. home.aspx



Sanofi, Regeneron dive deep on asthma in debut digital awareness campaign

June 03, 2019 / Beth Snyder Bulik

Most people know what asthma is, but even asthma patients can underestimate it. Sanofi and Regeneron’s new online disease awareness campaign highlights the problems of uncontrolled asthma. “The Next Breath” campaign, launched on World Asthma Day in May, aims to make patients, caregivers and others aware that uncontrolled moderate to severe asthma can have a big impact on daily life. On the website, several patients tell their personal stories about living with uncontrolled asthma in videos. Sanofi and Regeneron's biologic Dupixent added an indication for asthma in October. Sanofi’s own research found that up to 50% of asthma patients who have reported severe symptoms still consider their asthma to be well controlled, said Brian Foard, global lead for dermatology and respiratory at Sanofi Genzyme. According to the Centers for Disease Control and Prevention, more than 45% of people with asthma reported one or more asthma attacks. Patients learn to live with a ...